Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:1128 (2 June), doi:10.1136/bmj.39226.454236.3A
| The first 150 words of the full text of this article appear below. |
We agree with Fitzmaurice and Murray that the risks to patients of developing thromboembolism after surgery are well understood by clinicians.1 But the challenge of providing the recommended 100% compliance of prophylactic measures is substantial and can be met only by coordinated hospital wide strategies.
We recently completed an audit of thromboprophylaxis for surgical patients at a major oncological centre. Despite a high awareness of the risks, over 50% of our patients were not receiving their risk appropriate prescriptions of low molecular weight heparin. Correct use of mechanical prophylaxis was achieved in over 80% of patients. The practice of thromboprophylaxis varied substantially between different clinicians. Often no clearly designated doctor, surgeon, or anaesthetist was responsible in the team for implementing prophylaxis.
Patients should be classified into the risk categories suggested by the National Institute for Health and Clinical Excellence (NICE) at the earliest opportunity, such as in pre-assessment clinics, with
Christian Schwiebert, specialist registrar anaesthesia, Imperial School, Royal Brompton Hospital, London SW3 6NP, Barry G Lambert, specialist registrar anaesthesia, Imperial School, Queen Charlotte's Hospital, London W12 0HS
Queen Charlotte's Hospital, London W12 0HS
eureka.chris@doctors.org.uk